NeuRA has undertaken a review of research reproducibility and quality and established a formal Reproducibility & Quality Sub-Committee.
The members of the committee include both junior and senior scientists at NeuRA.
- Mr Andrew Affleck
- Prof Kaarin Anstey
- Dr Annie Butler
- Dr Andrew Cartwright
- Mr Aidan Cashin
- A/Prof Kim Delbaere
- Dr Michael Green
- Dr Martin Héroux
- Prof Stephen Lord
- Dr Euan McCaughey
- Prof Simon Gandevia (convenor)
There is a growing recognition that reproducibility of scientific results is not as robust as previously accepted. This has wide implications for all forms of research, but especially health and medical research. Initiatives have been undertaken in the United Kingdom (e.g. by the Academy of Medical Sciences, Wellcome Trust, Medical Research Council) and in the USA (e.g. by the National Institutes of Health) to address the reproducibility and quality of research.
In 2018, the Committee investigated the state of work on reproducibility and quality at different levels within Australia and overseas. In December 2018 its report was accepted by the NeuRA Research Committee and its recommendations will be implemented during 2019. The general recommendations are given below.
The recommendations propose changes that drive improvements in clinical and non-clinical medical research by NeuRA staff and thereby enhance NeuRA’s reputation as a research organisation.
The Committee would like to receive comments on this broad topic. Please send them to Simon Gandevia (firstname.lastname@example.org).
The general recommendations:
- Raise awareness about the importance of research reproducibility and quality and how this can be achieved.
- Educate and train researchers at all levels to improve research quality and the use of appropriate statistical methods.
- Foster an environment at NeuRA in which robust science and the validity of all research findings are prioritised.
- Promote open discussion of research reproducibility and quality with those at all levels within and outside NeuRA.
- Promote a culture of open high-quality science by encouraging strategies such as pre-registration of plans, making data available, and putting unpublished work in a publicly accessible location.
- Seek broad adoption of improved research quality and reproducibility at a national and international level.